ZS co-authored this piece with Richard Swank, principal and founder of Scientific Engagement LLC, an industry expert who has led medical science liaison teams in seven therapeutic areas, as well as nearly 20 product launches.
As organizations throughout the healthcare ecosystem strive to become more patient-centric, medical affairs teams are playing a critical role in helping improve patient outcomes. In a new white paper, we detail the four pillars of ZS’s medical affairs patient-centricity framework. This framework can help medical affairs teams decide where to proactively intervene, so they can help patients and healthcare professionals (HCPs), while working within a pharmaceutical organization’s broader goals.
For pharma organizations that want to improve their patient centricity, the first step is to assess their maturity. The white paper includes a model that medical affairs teams can use to assess their patient-centricity maturity. Whether your organization is nascent, best-in-class or somewhere in between, there has never been a better time to explore how you can be more patient-centric and deliver better outcomes.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
